×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
VCYT – veracyte, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
VCYT
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
7/16
07:03 am
vcyt
Veracyte (VCYT) was upgraded by Piper Sandler to "strong-buy".
Low
Report
Veracyte (VCYT) was upgraded by Piper Sandler to "strong-buy".
7/15
06:04 am
vcyt
Veracyte (VCYT) was downgraded by Zacks Research from "strong-buy" to "hold".
Medium
Report
Veracyte (VCYT) was downgraded by Zacks Research from "strong-buy" to "hold".
7/14
08:04 am
vcyt
Veracyte (VCYT) had its price target raised by Canaccord Genuity Group Inc. from $42.00 to $60.00. They now have a "hold" rating on the stock.
Low
Report
Veracyte (VCYT) had its price target raised by Canaccord Genuity Group Inc. from $42.00 to $60.00. They now have a "hold" rating on the stock.
7/9
04:05 pm
vcyt
Veracyte to Release Second Quarter 2026 Financial Results on July 30, 2026
Medium
Report
Veracyte to Release Second Quarter 2026 Financial Results on July 30, 2026
7/9
09:00 am
vcyt
Veracyte (VCYT) had its "underweight" rating reaffirmed by Morgan Stanley.
Medium
Report
Veracyte (VCYT) had its "underweight" rating reaffirmed by Morgan Stanley.
7/9
07:33 am
vcyt
Veracyte (VCYT) was upgraded by Zacks Research from "hold" to "strong-buy".
Medium
Report
Veracyte (VCYT) was upgraded by Zacks Research from "hold" to "strong-buy".
7/8
08:12 pm
vcyt
All You Need to Know About Veracyte (VCYT) Rating Upgrade to Strong Buy [Yahoo! Finance]
Medium
Report
All You Need to Know About Veracyte (VCYT) Rating Upgrade to Strong Buy [Yahoo! Finance]
7/4
09:41 am
vcyt
A Veracyte Insider Sold 24,000 Company Shares for $1.1 Million. Here's a Deeper Look at the Transaction. [Globe and Mail, The (Toronto, Canada)]
Low
Report
A Veracyte Insider Sold 24,000 Company Shares for $1.1 Million. Here's a Deeper Look at the Transaction. [Globe and Mail, The (Toronto, Canada)]
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
6/22
04:31 pm
vcyt
Form 4 VERACYTE, INC. For: Jun 18 Filed by: EASTHAM KARIN
Low
Report
Form 4 VERACYTE, INC. For: Jun 18 Filed by: EASTHAM KARIN
6/18
04:23 pm
vcyt
Form 144 VERACYTE, INC. Filed by: EASTHAM KARIN
Low
Report
Form 144 VERACYTE, INC. Filed by: EASTHAM KARIN
6/15
04:56 pm
vcyt
Form 4 VERACYTE, INC. For: Jun 11 Filed by: EPSTEIN ROBERT S
Medium
Report
Form 4 VERACYTE, INC. For: Jun 11 Filed by: EPSTEIN ROBERT S
6/15
04:56 pm
vcyt
Form 4 VERACYTE, INC. For: Jun 11 Filed by: Shafer David Brent
Medium
Report
Form 4 VERACYTE, INC. For: Jun 11 Filed by: Shafer David Brent
6/15
04:56 pm
vcyt
Form 4 VERACYTE, INC. For: Jun 11 Filed by: Miller Thomas F.
Medium
Report
Form 4 VERACYTE, INC. For: Jun 11 Filed by: Miller Thomas F.
6/15
04:56 pm
vcyt
Form 4 VERACYTE, INC. For: Jun 11 Filed by: Holstein Jens
Medium
Report
Form 4 VERACYTE, INC. For: Jun 11 Filed by: Holstein Jens
6/15
04:56 pm
vcyt
Form 4 VERACYTE, INC. For: Jun 11 Filed by: Barr Eliav
Medium
Report
Form 4 VERACYTE, INC. For: Jun 11 Filed by: Barr Eliav
6/15
04:56 pm
vcyt
Form 4 VERACYTE, INC. For: Jun 11 Filed by: JONES EVAN/ FA
Medium
Report
Form 4 VERACYTE, INC. For: Jun 11 Filed by: JONES EVAN/ FA
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
3/23
Form 4 VERACYTE, INC. For: Mar 20 Filed by: Anderson Bonnie H
16.7%
3/25 Form SEC STAFF LETTER VERACYTE, INC. 15.6%
2/29 Veracyte Inc (NASDAQ: VCYT) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. 8.3%
12/4 Veracyte Inc (NASDAQ: VCYT) was downgraded by analysts at BidaskClub from a "buy" rating to a "hold" rating. 7.9%
4/24 Form DEFA14A VERACYTE, INC. 7.9%
6/27 Veracyte to Release Second Quarter 2019 Financial Results on July 30, 2019 7.5%
8/12 Form 4 VERACYTE, INC. For: Aug 09 Filed by: JONES EVAN/ FA 6.7%
10/26 Veracyte Inc (NASDAQ: VCYT) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $29.00 price target on the stock. 6.5%
4/7 Veracyte Names Tracy Morris as Vice President of Corporate Communications and Investor Relations 6.3%
10/19 Veracyte Inc (NASDAQ: VCYT) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $29.00 price target on the stock. 6.1%
3/25 Form SEC STAFF LETTER VERACYTE, INC. 15.6%
2/29 Veracyte Inc (NASDAQ: VCYT) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. 8.3%
12/4 Veracyte Inc (NASDAQ: VCYT) was downgraded by analysts at BidaskClub from a "buy" rating to a "hold" rating. 7.9%
4/24 Form DEFA14A VERACYTE, INC. 7.9%
6/27 Veracyte to Release Second Quarter 2019 Financial Results on July 30, 2019 7.5%
8/12 Form 4 VERACYTE, INC. For: Aug 09 Filed by: JONES EVAN/ FA 6.7%
10/26 Veracyte Inc (NASDAQ: VCYT) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $29.00 price target on the stock. 6.5%
4/7 Veracyte Names Tracy Morris as Vice President of Corporate Communications and Investor Relations 6.3%
10/19 Veracyte Inc (NASDAQ: VCYT) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $29.00 price target on the stock. 6.1%
TOP News Decliners
4/1
Veracyte Announces Novel Gene Fusion Detection with the Afirma Xpression Atlas, Which May Inform Targeted Treatment Decisions for Thyroid Cancer Patients
-16.6%
3/11 Form 4 VERACYTE, INC. For: Mar 10 Filed by: Anderson Bonnie H -16.1%
10/22 Veracyte Announces Third Quarter 2019 Financial Results and Business Progress -15.7%
8/13 Form 4 VERACYTE, INC. For: Aug 12 Filed by: Anderson Bonnie H -8.2%
2/21 Veracyte Inc (NASDAQ: VCYT) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating. -8.1%
10/24 Veracyte Inc (NASDAQ: VCYT) was downgraded by analysts at ValuEngine from a "hold" rating to a "sell" rating. -7.3%
9/3 Veracyte Announces Publication of New Study Characterizing Gene Alterations in Thyroid Cancer -7.1%
8/1 Veracyte Inc (NASDAQ: VCYT) was downgraded by analysts at ValuEngine from a "strong-buy" rating to a "buy" rating. -6.8%
7/30 Form 10-Q VERACYTE, INC. For: Jun 30 -6.7%
4/14 Form 8-K VERACYTE, INC. For: Apr 13 -6.3%
3/11 Form 4 VERACYTE, INC. For: Mar 10 Filed by: Anderson Bonnie H -16.1%
10/22 Veracyte Announces Third Quarter 2019 Financial Results and Business Progress -15.7%
8/13 Form 4 VERACYTE, INC. For: Aug 12 Filed by: Anderson Bonnie H -8.2%
2/21 Veracyte Inc (NASDAQ: VCYT) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating. -8.1%
10/24 Veracyte Inc (NASDAQ: VCYT) was downgraded by analysts at ValuEngine from a "hold" rating to a "sell" rating. -7.3%
9/3 Veracyte Announces Publication of New Study Characterizing Gene Alterations in Thyroid Cancer -7.1%
8/1 Veracyte Inc (NASDAQ: VCYT) was downgraded by analysts at ValuEngine from a "strong-buy" rating to a "buy" rating. -6.8%
7/30 Form 10-Q VERACYTE, INC. For: Jun 30 -6.7%
4/14 Form 8-K VERACYTE, INC. For: Apr 13 -6.3%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: